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P46a b s t r a c t
Cutaneous leishmaniasis as caused by Leishmania major is a zoonotic infection with wide epidemiological
impact. The L. major P46 virulence gene was shown to boost the parasite’s virulence and extends its range
of experimental hosts. Here we show that P46 is subject to signiﬁcant geographical sequence variations
that may reﬂect the adaption to different reservoir hosts. This view is supported by the results of passage
experiments using P46 variants in different experimental hosts. Conversely, loss of P46 expression leads
to attenuation both in vitro and in BALB/c mice. Although part of the L. major exosomal protein payload,
P46 is not required for exosome-mediated immune modulation.
 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The protozoan parasite Leishmania major is an important caus-
ative agent of zoonotic cutaneous leishmaniasis (CL) in Eurasia
and Africa and causes localised, self-healing skin lesions that leave
severe scarring. L. major has a wide distribution, from West Africa
to Central Asia. Humans are not the main hosts of L. major, but
rather rodents of the Muridae family, mostly of the Gerbillinae
and Murinae subfamilies. L. major is mainly transmitted by female
Phlebotomus papatasi sandﬂies whose geographical distribution
matches that of zoonotic Old World CL.
Leishmaniae undergo a bipartite life cycle. Flagellated, cigar-
shaped promastigotes are transmitted by sandﬂies, while in the
mammal, the parasites reside as aﬂagellated, ovoid amastigotes
within the endocytotic compartment of macrophages and other
phagocytic cells. Leishmaniae are devoid of transcription control,
relying instead on gene ampliﬁcation, RNA stability, and regulated
translation for gene expression modulation (Clayton, 2002). Old
World leishmaniae also lack RNA interference, allowing for thestable propagation and expression of circular and linear episomal
DNA (Lye et al., 2010). This feature is crucial for the genetic
manipulation of leishmaniae using targeted overexpression and
functional cloning of genes (Clos and Choudhury, 2006).
Functional complementation of attenuated parasite strains
identiﬁed so-called virulence genes (Ryan et al., 1993b). This
approach was also used to search for genes able to complement
or compensate for the loss of the amastigote-speciﬁc heat shock
protein 100. Hsp100 is dispensable in the in vitro cultured para-
sites, but crucial for intracellular survival (Hübel et al., 1997;
Krobitsch and Clos, 1999), most likely through its pivotal role in
exosome payload selection (Silverman et al., 2010b). By passage
of a cosmid library-transfected, avirulent Hsp100 null mutant pop-
ulation through susceptible BALB/c mice, a dose-dependent, viru-
lence-stimulating gene was identiﬁed (Reiling et al., 2010). The
gene, LmjF33.0360 or P46, encodes a 46 kD protein of so far
unknown function that is exported from the amastigote into the
cytosol of the macrophage. Overexpression of P46 rescues the
virulence of Hsp100 null mutants and boosts the virulence of
the L. major reference strain MHOM/TM/1973/5ASKH (MAJ-01),
increasing the lesion formation in the L. major-susceptible mouse
strain BALB/c. Moreover, P46 overexpression enabled the parasite
to cause lasting skin lesions in normally resistant C57BL/6 mice,
thereby widening the range of experimental hosts.
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sequence variation and that these variations have an impact on
host speciﬁcity. Moreover, we show that the loss of P46 reduces
infectivity, in keeping with its proposed status as a virulence factor.2. Materials and methods
2.1. Parasite culture
2.1.1. L. major culture
Promastigote L. major were grown at 25 C in modiﬁed Med-
ium199 (Sigma–Aldrich, with 20% heat inactivated FCS, 40 mM
HEPES, pH 7.4, 0.2% NaHCO3, 100 lM adenin, 1.2 lg ml1 6-biop-
terin, 10 lg ml1 haem, 20 lg ml1 gentamicin, 2 mM L-glutamin,
pH 7.0). For macrophage and mouse infection experiments, para-
sites were allowed to grow to stationary phase. Promastigotes
were counted using a CASY cell counter (Roche).2.1.2. Episomal transfection
L. major promastigotes were taken from a late log phase culture,
washed twice in ice-cold PBS, once in electroporation buffer and
resuspended at a density of 1  108 ml1 in electroporation buffer
(Kapler et al., 1990; Laban and Wirth, 1989). 15 lg of circular DNA
were added to 0.4 ml of cell suspension and mixed in a 4 mm elec-
troporation cuvette on ice. The mixture was immediately subjected
to electroporation using a Gene Pulser apparatus (BioRad, Mün-
chen, Germany). Electrotransfection was carried out by three
pulses at 2.750 V/cm and 25 lF. The cells were chilled on ice for
10 min and transferred to 10 ml of drug-free medium. Selection
of transfected cells was carried out by adding antibiotics, as
G418 (50 lg ml1, Roth, Karlsruhe, Germany) or puromycin
(25 lg ml1, Sigma–Aldrich, München, Germany) to the cells 24 h
post transfection.
Mock transfection was performed in identical fashion, without
DNA, to obtain negative control cultures for antibiotic selection.2.1.3. Gene replacement
Of the P46 50 non-coding region, 1069 bp were ampliﬁed and
ﬁtted with EcoRI and KpnI sites at the 50 and 30 ends, respectively,
and ligated between the same sites in pUC19 (Yanisch-Perron et al.,
1985) to yield pUC-P46-50. Next, 1034 bp of the P46 30-non-coding
region were ampliﬁed and ﬁtted with BglII and HindIII sites at the
50 and 30 ends, respectively, and ligated between the same sites in
pUC-P46-50 to yield pUC-P46-50 + 30 (Fig. S4C).
Neomycin and Puromycin resistance genes, together with 50-
and 30-non-coding sequences of the Trypanosoma cruzi GAPDH-
gene were ampliﬁed from the plasmids pCL3P and pCL2N using
the primers GAPDH-fwd and GAPDH-rev, respectively (Fig. S4A
and B) to introduce KpnI and BamHI sites to the 50- and 30 ends,
respectively. The PCR products were digested and inserted
between the respective restriction sites in pUC-P46-50 + 30 to yield
pUC-P46-50neo30 and pUC-P46-50puro30 (Fig. S4D and E).
Gene replacement was performed in two steps with 2 lg of
each linearised replacement constructs (Fig. S4F and G) as
described (Hübel et al., 1997; Ommen et al., 2010). Transfected
cells were selected by their antibiotic resistances. Clones were
obtained by seeding the preselected population at 0.5 cells/well
in a 96-well plate in supplemented M199 (M199+). After
10–14 days, wells positive for promastigote growth were identiﬁed
and the clonal populations were transferred to culture ﬂasks. The
single allele gene replacement mutants were then subjected to a
second transfection step with the second replacement construct.
Selection for the double allele gene replacement mutants was
carried out under G418 and puromycin.2.1.4. Episomal expression constructs
The vector pTLv6 has been described (Hombach et al., 2013).
P46 variants were ampliﬁed with KpnI and BamHI sites respectively
at their 50- and 30 ends and ligated between KpnI and BglII sites in
pTLv6 (Fig. S5A). The plasmid pEB3S is derived from pcosP46
(Reiling et al., 2010) by replacing the NeoR marker gene against
the SAT marker which confers nourseothrycine (ClonNAT) resis-
tance (Fig. S5B).
2.1.5. Genomic DNA preparation and PCR
Mutant genotypes were veriﬁed by PCR analysis of genomic
DNA (gDNA). Genomic DNA was puriﬁed using the Gentra Systems
Puregene Tissue Core Kit A (Qiagen, Hilden, Germany) following
the manufacturer’s instructions.
The gene-replacement of P46 was veriﬁed by PCR using the oli-
gonucleotides LmjP46-001 and LmjP46-1257 (Table S2). To
exclude gDNA degradation as reason for failed ampliﬁcation, all
isolated gDNAs were used as templates in a PCR with the primers
LmjHSP23-KpnI and LmjHSP23-BamHI which target the HSP23
gene (Table S2).
2.2. Infection models
2.2.1. In vitro infection model
Murine bone marrow macrophages (BMM) were isolated from
the femurs of female C57BL/6 mice and differentiated in Iscove’s
Modiﬁed Dulbecco’s Medium (IMDM) supplemented with 10% heat
inactivated FCS, 5% horse serum, and 30% L929 supernatant (mod-
iﬁed after (Racoosin and Swanson, 1989)). For infection, BMMwere
harvested, washed, and seeded into the wells of an 8-well chamber
slide (NUNC) at a density of 4  105 cells/well. The macrophages
were incubated for 48 h at 37 C and 5% CO2 to allow adhesion of
the cells. Adherent BMM were infected with stationary phase
promastigotes (Racoosin and Beverley, 1997) at a multiplicity of
infection of 10 parasites per macrophage. After 4 h of incubation
at 37 C in modiﬁed Medium199, non-phagocytosed parasites
were removed by multiple washing steps with PBS and incubation
was continued for another 24 h in IMDM at 37 C and 5% CO2. The
medium supernatants were removed. The cells were washed twice
and ﬁxed in ice-cold methanol. Intracellular parasites were quanti-
ﬁed by nuclear staining with DAPI (1.25 lg ml1, Sigma) and ﬂuo-
rescence microscopy.
2.2.2. Mouse passage
Animal passage was conducted in accordance with §10a, Ger-
man Animal Protection Laws. Three days prior to infection, para-
sites were grown in modiﬁed Medium199 until stationary phase
was reached. Parasites were washed twice and resuspended in
pre-chilled phosphate buffered saline pH 7.0 (PBS). Parasite sus-
pension (1–4  106 in 50 ll PBS) was inoculated s.c. into the rear
foot pads of BALB/c or C57BL/6 mice. Footpad size was monitored
weekly. Mice were sacriﬁced before lesions ulcerated. For parasite
reisolation, the lesion tissues were prepared, homogenised and
suspended in modiﬁed Medium199 and the appropriate antibiotic
pressure was applied. The medium was also supplemented with
penicillin/streptomycin (100 PenStrep, Sigma) to avoid bacterial
contamination.
For the quantiﬁcation of the parasite loads the draining popli-
teal lymph nodes (popLNs) were prepared and used for gDNA puri-
ﬁcation. The RT-qPCR was performed as described underneath.
2.3. Semi-quantitative real time PCR (RT-qPCR)
RT-qPCR was performed essentially as described (Choudhury
et al., 2008). P46 gene-speciﬁc primers were P46-B1 and P46-F1
(Table S2). P46 mRNA abundance was calculated relative to the
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actin B2 (Table S2).
The parasite loads in the popLNs was calculated by normalising
the Leishmania actin signal relative to the murine actin signal
obtained with primers M-actin fwd and M-actin rev (Table S2).
2.4. Phylogenetic studies
2.4.1. Genes and primers
The phylogenetic studies were performed with the genes P46
(22 L. major isolates), HSP23 (9 isolates), and HIP (7 isolates). The
genes were ampliﬁed from gDNA using the gene-speciﬁc primers
listed in the Supplementary data (Table S2) and a proof-reading
ampliﬁcation kit (iProof, BioRad, Munich). After ampliﬁcation, the
PCR products were puriﬁed, digested and inserted into pUC19.
The plasmids were then sent to LGC-Genomics GmbH (Berlin,
Germany) for bi-directional sequencing with the universal primers
M13-24F and M13-24R. Chromatographs were inspected for possi-
ble sequence ambiguities using the MacVector software package
before sequence assembly. Ambiguous sequences were excluded.
2.4.2. Variant-speciﬁc P46 PCR
Parasite populations reisolated from lesion tissues were sub-
jected for alkaline plasmid preparation. Escherichia coli were trans-
formed with the puriﬁed plasmids (0.01–1 lg) and allowed to
growth for 8 h (37 C) on LB-plates under ampicillin (100 lg ml1)
selection. Plasmids from 50 bacterial colonies for each Leishmania
isolate were used as templates for PCR with the primers P46-diff-
fwd and P46-diff-rev, which ﬂank a threonine codon cluster of
varying length. The PCR product length polymorphism was
resolved on a non-denaturing 12% (w/v) polyacrylamide gel in
1 Tris–Borate–EDTA buffer (TBE) (Sambrook and Russell, 2001).
The gels were stained with ethidium bromide (0.5 lg ml1 in
TBE) for the detection with UV-light.
2.4.3. Phylogenetic analysis
Amino acid sequences were deduced from the coding nucleo-
tide sequences and alignments were performed using the MUSCLE
tool (Edgar, 2004a,b) included in the MacVector DNA Analysis Soft-
ware package (version 12.7.4), using default parameters. Tree
building was done using UPGMA and Best Tree mode, displaying
uncorrected distances.
2.5. Protein methods
2.5.1. Isolation of L. major exosomes
1  109 L. major promastigotes from a late log-phase culture
were washed twice in ice-cold PBS, seeded into 10 ml of serum-
free M199+ and kept at 37 C for 24 h. The cells were then sepa-
rated from the medium by centrifugation at 500g (4 C). The
medium was subjected to ﬁltration (0.22 lm) and concentration
of the exosomes (Centricon Plus-70 MWCO 100,000 Da, Milli-
pore). The concentrated exosomes were loaded on a sucrose cush-
ion (2 ml ice-cold PBS over 750 ll ice-cold 1 M sucrose solution) in
an ultra-clear Beckman Coulter 5.2 ml tube. The tubes were sub-
jected to ultracentrifugation for 2 h at 100,000g (4 C) and
washed with ice-cold PBS, followed by a second ultra-centrifuga-
tion step in 1.5 ml tubes (Microfuge Tube, Beckman Coulter)
for 1.5 h at 125,000g (4 C).
The exosomes were resuspended in a 20 mM Tris–HCl (pH 7.4)
buffer and stored at 20 C.
2.5.2. Trypsin digestion
To verify intact exosomes, they were suspended either in
20 mM Tris–HCl (pH 7.4) buffer, 20 mM Tris–HCl (pH 7.4) with
40 lg ml1 Trypsin or Tris–HCl (pH 7.4) with 0.1% Triton X-100and 40 lg ml1 Trypsin. The samples were then incubated at
37 C for 1 h and subjected to SDS–PAGE followed by Western
blotting.
2.5.3. SDS–PAGE and Western blotting
Production of SDS cell lysates, discontinuous SDS–PAGE and
Western blot were performed according to our established proce-
dures (Brandau et al., 1995), using FluoroTrans PVDF membranes
(Pall). Membranes were blocked (5% milk powder in Tris-buffered
saline, 0.1% Tween 20), probed with polyclonal chicken IgY anti-
bodies (1:100–500 in blocking solution) before incubation with
an anti-chicken IgY-alkaline phosphatase conjugate (1:2500, Dia-
nova). Blots were developed using nitro blue tetrazolium chloride
and 5-bromo-4-chloro-3-indolyl phosphate (Sigma).
2.6. Microscopy
2.6.1. Giemsa staining and bright ﬁeld microscopy
Promastigotes were smeared onto glass microscope slides and
air-dried, followed by ﬁxation in ice-cold methanol (10 min).
Infected macrophages in chamber slides (NUNC) were ﬁxed with
ice-cold methanol before the chamber separations were removed.
Slides were then submerged in 10% (v/v) Giemsa staining solution
(Sigma–Aldrich) for 10 min, brieﬂy washed in tap water and set to
dry. The inverted slides were viewed and photographed on an
EVOS XL inverted bright ﬁeld microscope.
2.6.2. Scanning electron microscopy
Concentrated exosomes (2.5.1) were ﬁxed in 2% glutaraldehyd
in a sodium cacaodylate buffer and post-ﬁxed with 1% osmium.
Samples were dehydrated at increasing ethanol concentrations
(30–100%). After critical point drying, samples were treated with
gold and analysed on a Philips SEM 500 electron microscope.
Images were taken using a conventional 35 mm camera, and the
developed black-and-white ﬁlms were digitalised using a HAMA
35 mm ﬁlm scanner (Monheim, Germany).3. Results
3.1. P46 expression is uniform in L. major isolates
The Central Asian strain MHOM/TM/1973/5ASKH (MAJ-01)
causes very limited skin lesions in resistant C57BL/6 mice that dis-
appear quickly. However, another laboratory strain of L. major,
MHOM/IL/81/FE/BNI (FE/BNI), was reported to be naturally viru-
lent in C57BL/6 mice (Ritter et al., 2004), causing temporary
lesions. We have therefore investigated whether differences in
P46 structure or expression may be involved in strain speciﬁc vir-
ulence modulation. We obtained a freshly passaged stock of L.
major FE/BNI and transfected this strain with either the empty cos-
mid vector pcosTL (Kelly et al., 1994) or the pcosP46 plasmid
(Reiling et al., 2010) that encodes L. major (MAJ-01) P46 as an epi-
some. Quantiﬁcation of gene copy numbers indicated an 30-fold
increase due to pcosP46 episomes (Fig. 1A). Increase of P46 RNA
due to pcosP46 episomal DNA was quantiﬁed by semiquantitative
RT-qPCR as 60-fold (Fig. 1B). Both recombinant stocks were then
used to inoculate C57BL/6 mice. We followed the lesion develop-
ment at weekly intervals. Unlike the strain L. major MAJ-01 which
is non-pathogenic in C57BL/6 mice and needs P46 overexpression
to cause lesion formation (Reiling et al., 2010), the FE/BNI control
strain carrying the empty pcosTL cosmid causes moderate footpad
swelling by itself (Fig. 1C, open diamonds). Nevertheless, the over-
expression of P46 derived from MAJ-01 in FE/BNI increases footpad
swelling considerably (solid diamonds), indicating that the ele-
vated basic virulence of this strain can be further enhanced by
Fig. 1. (A) P46 gene copy numbers determined by semi-quantitative real time PCR in L. major strain FE/BNI transfected with either pcosTL (open diamonds) or pcosP46 (solid
diamonds); log2 scale. (B) P46-speciﬁc RNA levels determined by semi-quantitative RT real-time PCR in L. major strain FE/BNI transfected with either pcosTL (open diamonds)
or pcosP46 (solid diamonds); log2 scale. (C) C57BL/6 mice were infected with either L. major FE/BNI (open diamonds) or L. major FE/BNI [pcosP46] (solid diamonds). Footpad
swelling was monitored over 60 days. n = 2. Experimental procedures were described (Reiling et al., 2010). (D) P46-speciﬁc RNA levels determined by semi-quantitative RT
real-time PCR in 3 L. major strains; MAJ-01, MAJ-13, and FE/BNI. qPCR was performed in quadruplicate. Horizontal bar = median; log2 scale.
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quantitative or qualitative differences in P46 might be causal for
the elevated virulence of FE/BNI.
We ﬁrst tested the expression of P46 in three L. major laboratory
strains. In particular, we compared P46-speciﬁc RNA levels of MAJ-
01, L. major Friedlin strain (MAJ-13), and FE/BNI using RT-qPCR
analysis for promastigotes of each strain. The results (Fig. 1D)
indicate absolutely uniform P46 RNA levels. This excludes P46
expression levels as cause for the increased virulence of strain
FE/BNI. We therefore investigated the possibility of sequence
variations between P46 genes of the L. major strains.
3.2. Geographical variations in the P46 sequence
In a previous paper (Reiling et al., 2010) we had not seen
sequence variations between our P46 expression plasmids derived
from MAJ-01 and the sequence in the L. major genome database
(LmjF33.3060). Nevertheless, we repeated the analysis amplifying
the P46-coding regions from genomic DNA of MAJ-01 and FE/BNI
using a proof-reading PCR kit. Sequences of P46 PCR products
derived from either parasite strain differed consistently and repro-
ducibly. FE/BNI P46 carries 3 nucleotide sequence polymorphisms
compared with MAJ-01, all of which cause amino acid exchanges.
In addition, a stretch of 9 threonine amino acids near the C0 termi-
nus is reduced by one threonine in the putative FE/BNI sequence
(Fig. S1). We repeated the entire procedure using DNA from strain
MAJ-13 (Friedlin) which was used for the L. major genome project
(Ivens et al., 2005). The resulting P46 sequence was identical to FE/
BNI. We therefore suspected that P46 may be subject to geograph-
ical sequence variation since MAJ-01 is a Central Asian isolate orig-
inally from Turkmenistan (Al-Jawabreh et al., 2008), while both
MAJ-13 and FE/BNI originate from Israel (Table S1) and have been
adapted to the laboratory for at least 2 decades (Ryan et al., 1993a;
Solbach et al., 1986).To clarify whether P46 sequence also varies in the ﬁeld, we
assembled genomic DNA samples of L. major isolates from different
geographical origins (Fig. 2A). In addition to using samples from
highly varying geographical regions (Al-Jawabreh et al., 2008),
we also included 10 samples from CL cases treated in Mazar-i-Sha-
rif, Afghanistan, to test the variability within a reasonably deﬁned
endemic area. Using high ﬁdelity PCR we ampliﬁed and sequenced
P46 coding sequences from those isolates. We found nucleotide
sequence variations in the cloned PCR products that changed a lim-
ited set of codons, but did not introduce reading frame shifts. We
deduced amino acid sequences and aligned them for comparison.
The results (Fig. S1) show that the P46 amino acid sequence varied
in a total of 9 positions. In addition, the length of an oligo-threo-
nine (T) stretch near the C0 terminus varied between 6 and 11 thre-
onines. We used the alignment to generate a phylogenetic tree
(Fig. 2B). We found that 8 out of ten P46 sequences from isolates
originating in Afghanistan and two derived from Central Asian iso-
lates (MAJ-01, MAJ-80) were identical, indicating that regional P46
sequence variants are maintained stably. Close to those 10
sequences, we could group another Afghan isolate and two isolates
from Israel. Neighbouring, but clearly distinct, are the two labora-
tory strains FE/BNI and MAJ-13 (Friedlin), in spite of their origin in
Israel. A more varied group is formed by the isolates from Africa,
Turkey and Iran. The strongest anomaly we found was the position
of one Afghan isolate (Pat 15) that was found to be identical to the
Moroccan isolate (MAJ-46). We speculate that the patient may
have acquired the infection in Northern Africa. Isolates MAJ-59
(Iran) and MAJ-42 (Turkey) are close to the African/Mediterranean
group. Both were identiﬁed as belonging to an African clade in an
earlier multilocus microsatellite typing study (Al-Jawabreh et al.,
2008), matching the results we obtained with the P46 sequence
variations.
To exclude that a random genetic drift underlies these varia-
tions, we also ampliﬁed, cloned, and sequenced the coding regions
Fig. 2. (A) Map of Old World highlighting the countries of origin for the L. major isolates used in the study. (B) Phylogenetic tree of P46 sequence variants showing
uncorrected distances. Strain names are colour-coded according to their geographic origin. Phylogenetic tree of HIP (C) sequences, and Hsp23 (D) sequences. Same colour
coding as (B). Genes were ampliﬁed using the iProof high ﬁdelity PCR Kit (BioRad) and inserted into pUC19 plasmid for cloning and sequencing. Nucleotide and amino acid
sequence alignments were performed using the MUSCLE tool (Edgar, 2004a) included in the MacVector DNA Analysis Software package (version 12.7.4), using default
parameters. Tree building was done using UPGMA and ‘‘Best Tree’’ mode, displaying uncorrected distance. (For interpretation of the references to colour in this ﬁgure legend,
the reader is referred to the web version of this article.)
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Fig. 3. Effect of P46 sequence variation in vivo and in vitro. (A) Selection experiment.
L. major MAJ-01 carrying P46 transgenes from MAJ-01, FE/BNI, and MAJ-48 were
mixed at equal ratios. The mixture was inoculated into the footpads of BALB/c or
C57BL/6 mice. Alternatively, the mixture was subjected to in vitro passage. Parasites
were recovered and plasmid transgenes were isolated and transformed into E. coli.
Plasmids from 50 E. coli clones per isolate were subjected to product length
polymorphism PCR and non-denaturing 12% polyacrylamide electrophoresis. The
stacking bar graph shows the distribution of P46 variants after the three different
selections. (B) Intracellular in vitro selection. L. major MAJ-01 transfected with
empty plasmid (control) or P46 transgenes derived from three L. major strains (MAJ-
01, FE/BNI, and MAJ-48) were used to infect BMMs in vitro. After 24 h, infected
macrophages were stained with DAPI. The parasite load of 50 macrophages each
was determined by ﬂuorescence microscopy. The error bars show the standard
deviation. n = 4; ⁄⁄⁄p 6 0.001 (U-test). Experimental procedures were described
(Reiling et al., 2010).
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(HIP) (Ommen et al., 2009) and a small heat shock protein,
Hsp23 (Hombach et al., 2014). No sequence variation is observed
at all for HIP (Fig. 2C), and the minor variations observed with
Hsp23 do not correlate with the geographical origin (Fig. 2D).
Therefore, the sequence variations in P46 are not the result of a
general genetic drift, but are likely the result of geographically dis-
tinct selective pressures.
3.3. P46 variation impacts on host speciﬁcity
For L. major, humans are accidental hosts and do not contribute
to the pathogen reservoir. In the various endemic regions, L. major
is subject to a zoonotic infection cycle between various rodents,
ranging from gerbils, hamsters and fat sandrats (Gerbillinae) to
Muridae (African Grass Rat), and their arthropod hosts, Phleboto-
mus spp. Since P46 was identiﬁed as virulence factor in a rodent
host, we suspected that the P46 sequence variations may contrib-
ute to the adaption to different reservoir hosts (Elfari et al.,
2005). Due to the difﬁculties to obtain, breed and use relevant res-
ervoir animals from the endemic regions, we resorted to a simple
passage experiment in laboratory mice to test our hypothesis.
We identiﬁed three P46 variants, namely from MAJ-01, FE/BNI,
and MAJ-48, that can be distinguished from each other by a length
polymorphism in the region coding for the C0-terminal threonine
cluster (Fig. S1). Those three prototype P46 sequences represent
Central Asia (MAJ-01), Middle East (FE/BNI), and Africa (MAJ-48)
(Table S1). We inserted all three variants into the expression vector
pTLv6 (Hombach et al., 2013) (Fig. S5) and transfected the resulting
expression plasmids as stable episomes into MAJ-01 parasites, cre-
ating three overexpressing strains. Equal numbers of these, each
expressing one of the three P46 variants, were then mixed and
inoculated into susceptible BALB/c and infection-resistant C57BL/
6 mice. After 8 weeks of passage, the mice were sacriﬁced to
recover the selected parasite populations. Their plasmid DNA was
isolated and used to transform E. coli. For each plasmid re-isolation,
50 bacterial colonies were analysed by PCR to identify the selected
P46 variants by length. Three passages were performed for each
mouse strain. We also grew the mixed recombinant population
in vitro, to determine the effects of P46 sequence variation on
proliferation.
The results of the selections are shown in Fig. 3A. The in vitro
cultivation favours the outgrowth of the two P46 variants from
the laboratory-adapted strains MAJ-01 and FE/BNI, while we recov-
ered equal percentages of P46 variant transgenes after passage in
susceptible BALB/c mice. After selection in C57BL/6 mice, however,
the P46MAJ-48 was strongly favoured at 56%. The P46FE/BNI was also
successful at 31%, whereas the P46MAJ-01 was not favoured (13%).
The selections show that P46 sequence polymorphisms can be
advantageous or detrimental depending on the passage conditions.
P46FE/BNI appears to be the best all-around compromise to allow
proliferation in vitro and in mice, likely a consequence of 25 years
of laboratory passage. By contrast, the P46MAJ-01 performed well
in vitro but not in immune competent mice. P46MAJ-48 performs best
in immune competent C57BL/6 mice, while being at a disadvantage
in the in vitro cultivation. This may imply that the cultivation of
selected parasites prior to plasmid isolation may have masked an
even greater advantage of P46MAJ-48 in the in vivo selections.
We also tested the impact of P46 variations on L. major prolifer-
ation inside C57BL/6 bone marrow-derived macrophages. Each of
the strains overexpressing one of the three P46 prototypes plus a
control strain carrying the empty pTLv6 plasmid were used to
infect BMMs in vitro. After 24 h, we determined the percentage of
infected macrophages and the number of parasites per macro-
phage (parasite load). The infection rate did not vary signiﬁcantly
between the P46 variant overexpressing strains but was high at90% (not shown), indicating that P46 expression or variation is
not critical for in vitro parasite uptake by macrophages. Overex-
pression of any P46 variant increases the parasite load signiﬁcantly
(Fig. 3B). Here, P46FE/BNI shows the greatest effect, more than tri-
pling the parasite load. P46MAJ-01 and P46MAJ-48 cause a weaker
but signiﬁcant increase. All three variants are functionally active,
but those derived from laboratory adapted strains perform better
in vitro.3.4. P46 gene replacement
Given the obvious selection for P46 in the host we next under-
took to replace the P46 alleles in L. major. Our ﬁrst attempts using
selection marker genes ﬂanked by 1000 bp each of 50-non-coding
and 30-non-coding DNA from the P46 locus did not yield viable,
selectable cells, not even when we targeted single alleles only
(Chrobak and Zander, unpublished). Reasoning that the P46 ﬂank-
ing sequences may not support sufﬁcient selection marker gene
expression, we designed new replacement constructs with T. cruzi
GAPDH non-translated ﬂanking sequences on either side of the
selection markers. The resulting constructs pP46-puroR and
pP46-neoR are shown in Fig. S4 and were cut with SwaI to yield lin-
ear replacement DNA.
Mid-log phase L. major promastigotes were transfected sequen-
tially with linearised pP46-puroR and pP46-neoR DNA. Of 10 L.
Fig. 4. (A) P46-speciﬁc PCR. Genomic DNAs were prepared from L. major MAJ-01 wild type and from 4 suspected L. major P46/ clones (#1–#4). Using primers LmjP46-001
and LmjP46-1257, the P46 coding DNA (1275 bp) was ampliﬁed and subjected to 1% agarose gel electrophoresis. Lane 1, wild type DNA; lanes 3–6, P46/ clones #1–#4; lane
8, negative control (water), lanes 2 and 7, DNA size marker. Marker bands corresponding to 1 kb, 3 kb and 6 kb are indicated. (B) As in (A), but using HIP-speciﬁc primers
LmjHIP-50KpnI and HIP-30BglII to amplify HIP-coding DNA (800 bp). (C) Semi-quantitative real-time RT-PCR (qPCR). RNA isolated from wild-type L. major and from 3 P46/
clones (#1, #2, #4) was reversely transcribed and the resulting cDNA was used for P46-speciﬁc qPCR using primers P46-F1 and P46-B1 (Table S2). Results were normalised
against L. major actin cDNA (primers L-actin-fwd and L-actin-rev). Ampliﬁcation was performed in duplicate. (D) In vitro proliferation of L. majorwild type (solid squares) and
P46 null mutant clones #1 (open circles), #2 (triangles) and #4 (inverted triangles). X-axis shows days after inoculation, Y-axis shows cell density (cell ml1 E+06). (E)
Promastigote morphology of L. majorwild type and of P46 null mutant clone #4. Cells were dried on a microscope slide and stained after Giemsa. Microscopy was performed
in brightﬁeld at 100magniﬁcation. Size bar = 10 lm. (F) Amastigote morphology. Bone marrow-derived macrophages were infected with L. majorwild type and the P46 null
mutant respectively. After 24 h, infected cells were ﬁxed and stained after Giemsa. Microscopy was performed in brightﬁeld at 100 magniﬁcation. Size bar = 10 lm.
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puromycin, 4 clones were subjected to genotyping by PCR. All 4
clones were negative for P46 coding DNA (Fig. 4A), but allowed
ampliﬁcation of a control gene, HSP23 (Fig. 4B). We puriﬁed RNAsfrom 3 clones and subjected them ﬁrst to cDNA synthesis and then
to qPCR. All three clones tested were negative for P46 RNA
(Fig. 4C). We concluded that clones P46/ #1, P46/ #2 and
P46/ #4 are double-allelic null mutants for P46.
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growth of promastigotes, we could not detect differences (Fig. 4D)
suggesting that although P46 sequence variations can be favoured
in vitro (Fig. 3A), its role in the promastigote is limited. We also did
not detect morphological differences, neither for promastigotes
(Fig. 4E) nor for intracellular amastigotes (Fig. 4F). Therefore,
replacement of the P46 alleles is not affecting L. major cells.
3.5. P46 null mutants are attenuated
We next subjected the P46 null mutants to a passage in BALB/c
mice to determine their pathogenicity and survival in this model
host. Wild type L. major caused rapid lesion formation within
2 weeks of inoculation. Lesion formation caused by two P46 null
mutant clones, P46/ #1 and P46/ #4, was considerably delayedFig. 5. (A) Pathogenicity in mice. L. major wild type (solid squares) and P46 null mutant
BALB/c mice (n = 4). Footpad swelling was monitored over 40 days. (B) Mice from (A) w
lymph nodes. L. major actin DNA was quantiﬁed by qPCR (primers L-actin-fwd and L-act
rev). Signiﬁcance (⁄⁄p < 0.01; ⁄⁄⁄p < 0.001) was determined using the U-test. The bars ind
(solid squares), L. major P46/ clone #4 (triangles), and L. major P46//+ were subjected
44 days (mutant clones). (D) Infectivity in vitro. L. major wild type (P46+/+), L. major P
macrophages at a 10:1 ratio. After 24 h, infected cells were ﬁxed and stained with DA
manually. (E) P46 RNA levels in L. major wild type (P46+/+), L. major P46/ clone #4, anand generally slower (Fig. 5A). When we determined the relative
parasite load in popliteal lymph node tissue recovered after pas-
sage, we observed a striking difference between wild type-infected
and null mutant-infected tissues (Fig. 5B). The median parasite
load caused by the null mutants was reduced by >90%, indicating
an impaired ability to survive inside the host.
We next tested whether an episomal P46 transgene can comple-
ment the null mutant. Wild type and null mutant parasites, plus a
null mutant expressing P46 from a plasmid were subjected to a
passage in BALB/c mice. While the null mutants (open triangles)
again cause a delayed lesion formation compared with the wild
type parasites (closed squares), the reconstituted null mutant (cir-
cles) shows no restored pathogenicity (Fig. 5C).
This is contrasted by the results of in vitro infections using bone
marrow-derived mouse macrophages (Fig. 5D). The P46 nullclones #1 (inverted triangles) and #4 (triangles) were subjected to passage through
ere sacriﬁced after 40 days. Genomic DNA (gDNA) was isolated from the draining
in-rev) and normalised against mouse actin DNA (primers M-actin fwd and M-actin
icate median values. (C) Pathogenicity after P46 gene add back. L. major wild type
to a passage in BALB/c mice. Foot swelling was monitored for 28 days (wild type) or
46/ clone #4, and L. major P46//+ were used to infect bone marrow-derived
PI. Parasite loads per macrophage from multiple infections (n = 4) were counted
d L. major P46//+ were determined by qPCR and in duplicate.
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with the wild type, mirroring the results of the mouse passages.
However, expression of a P46 transgene in the null mutant fully
restores the infectivity in vitro, conﬁrming that the loss of infectiv-
ity in the null mutant is indeed due to the lack of P46.
At present, we have no explanation for the different effects of
the P46 transgene in vivo and in vitro. We found out however, that
the P46 transgenes are expressed far more vigorously in the null
mutant (40-fold) compared with the endogenous gene (Fig. 5E),
again for reasons we cannot explain. Such a massive overexpres-
sion may cause adverse effects in a test animal that are not
reﬂected in an ex vivo macrophage infection model.3.6. P46 is exported via exosomes
As P46 was found in the cytosol of infected bone marrow
derived macrophages (Reiling et al., 2010) we undertook efforts
to investigate the export pathway of P46.
The experiments of Silverman et al. (2008) showed an exosome-
based protein export for approximately 50% of the Leishmania sec-
retome. Moreover exosomes transport known virulence factors and
are able to modulate the host immune response in vivo and in vitro.
The pro-parasitic effect of exosomes depends on Hsp100, which isFig. 6. (A) Scanning electron microscopic image of a putative exosome fraction from L. m
(lane 1), Trypsin + 1% Triton X-100 (lane 2) or left unchallenged (lane 3) and then subjec
was probed with anti-Hsp90 IgY. Size marker positions are shown to the left. (C) Western
2) and L. major Hsp100/ [pcos-P46] (lane 3). Replica membranes were probed with ant
are indicated on the right. (D) Effect of exosomes on in vitro infectivity of L. major. Bon
exosomes prepared from L. major wild type (P46+/+), L. major P46/ clone #4, or L. majo
respectively. After 24 h, infected cells were ﬁxed and stained with DAPI for ﬂuorescencecrucial for the exosome payload assembly (Silverman et al.,
2010a,b).
We therefore isolated exosomes from L. major to determine
whether P46 too is part of the payload and whether it plays a part
in the immune modulatory effects of the exosomes.
We ﬁrst ascertained the quality of our exosome preparations by
transmission electron microscopy. The images show clustered ves-
icle-like structures of exosome size (Fig. 6A). To conﬁrm those as
membrane-surrounded vesicles we treated the presumed exo-
somes with a peptidase according to Silverman et al. (2010a).
The exosome samples were divided in 3 fractions. One was treated
with Trypsin, one was treated with both Trypsin and Triton X-100,
and one remained untreated as a control. After an incubation at
37 C we performed a Western blot against Hsp90 (Fig. 6B), which
is a known payload protein of exosomes. As expected, no Hsp90
was detected in the sample treated with Triton X-100 and Trypsin
due to membrane-lytic function of Triton X-100. In the absence of
Triton X-100, Hsp90 was not degraded, conﬁrming the integrity of
the exosome vesicles.
This conﬁrmed, we then tested for P46 in exosome preparations
from L. major WT, L. major Hsp100/ and L. major Hsp100/ car-
rying an episomal P46 transgene. We could detect P46 in the pay-
load of all exosome preparations, with an increase in the exosomes
from the P46 overexpressing Hsp100/ mutant (Fig. 6C). Thisajor. Size bar = 2 lm. (B) Trypsin test. Exosome fraction was challenged with Trypsin
ted to 8% SDS–polyacrylamide gel electrophoresis and Western blot. The membrane
blot of exosomes derived from L. major wild type (lane 1), L. major Hsp100/ (lane
i-P46 IgY, anti-Hsp90 IgY and antiHsp100 IgY. Positions of relevant marker proteins
e marrow-derived macrophages were seeded into chamber slides, incubated with
r P46//+ or with medium (negative control) and infected with L. major (MAJ-01),
microscopic analysis. ⁄⁄⁄p < 0.001 relative to medium control.
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the exosomes. Western blots against Hsp100 and Hsp90 conﬁrmed
the Hsp100 null mutant and equal protein loading in all lanes.
Therefore, P46 overexpression can compensate for the loss of
Hsp100 (Reiling et al., 2010), but is independent of this heat shock
protein in its – so far unknown – function.
Given the suspected role of P46 as a virulence factor, we tested
the impact of the protein on the function of exosomes. Bone mar-
row-derived macrophages (BMMs) were incubated with exosomes
derived from L. majorWT, L. major P46/, L. major P46//+ or with
Leishmania-free medium, followed by an infection with wild type L.
major. The results of the in vitro infection (Fig. 6D) conﬁrmed a sig-
niﬁcant pro-parasitic effect of exosomes, which manifested itself in
the increased parasite load in exosome-treated vs. medium-treated
BMMs. This effect was not dependent on P46 since the null mutant
exosomes showed virtually identical effects. Therefore, P46 is a
non-essential, non-Hsp100-dependant exosomal protein.4. Discussion
Many factors contribute to the virulence of Leishmania. Exam-
ples for virulence factors are the enzymes and chaperones involved
in maintaining lipophosphoglycan biosynthesis (Beverley and
Turco, 1998), stress proteins required for survival inside the mam-
malian host cells (Hombach et al., 2013; Hübel et al., 1997;
Krobitsch and Clos, 1999; Silverman et al., 2010b; Zhang and
Matlashewski, 1997), and metallo- and cystein peptidases (Joshi
et al., 2002; Mottram et al., 2004, 1996). While some virulence
markers have a universal role in Leishmania spp. (Hübel et al.,
1997; Krobitsch and Clos, 1999), others show species-speciﬁc
impact (Turco et al., 2001), or are species-speciﬁc genes (Reiling
et al., 2010). What deﬁnes virulence may also differ depending
on the endemic region and the prevalent rodent hosts. L. major
from Central Asia fail to infect the rodents found in the Middle East
and Northern Africa, and vice versa (Elfari et al., 2005). This indi-
cates an adaption of L. major to the available rodent hosts in the
vastly different regions of endemicity, thus allowing for the almost
universal distribution of this parasite over large parts of the Old
World.
L. major isolates from the wild also adapt to in vitro cultivation,
giving rise to laboratory strains with well-deﬁned growth and
infectivity. Our results show that there is a sizeable difference
between the infectivity of two lab strains, namely MHOM/TM/
1973/5ASKH (MAJ-01) and MHOM/81/IL/FE/BNI (FE/BNI). Interest-
ingly, both strains vary not by their P46 expression strength, but by
their P46 primary structure. Also, the two laboratory adapted
strains originally from Israel, FE/BNI and MAJ-13 (Friedlin), show
identical P46 sequences, but differ signiﬁcantly from other Israeli
isolates that were not subjected to >20 years of laboratory passage.
By contrast, previous work using microsatellite typing techniques
(Al-Jawabreh et al., 2008) had grouped FE/BNI and MAJ-13 in the
context of their Israeli origin. This indicates a speciﬁc pressure to
adapt the P46 primary structure to the available rodent host. The
infections experiments further support this. MAJ-01 parasites car-
rying P46 transgenes from three geographical origins were selected
differently in vitro, in BALB/c mice and in C57BL/6 mice. Interest-
ingly, the P46 variant derived from the Senegalese MAJ-48 per-
formed best in the immune competent C57BL/6 mice which is
considered the best model and reﬂecting human infection (Ritter
et al., 2004). One of the reservoirs in West Africa is the African
Grass Rat, Arvicanthis niloticus, subfamily Murinae, which is evolu-
tionarily closer to Mus musculus than the members of the Gerbilli-
nae subfamily that are the reservoirs in the Middle East and Central
Asia. While the infection experiments do not constitute a validmodel for the adaption to real-life reservoirs, the result indicates
strongly that different living environments favour different P46
primary structures.
Fittingly, the related parasite Leishmania tropica which is pre-
dominant in urban settings and is able to maintain an anthropo-
notic infection cycle has no functional P46 gene. The region
corresponding to the L. major P46 gene is 90% conserved
(Fig. S2). However, the presence of multiple stop codons in the L.
tropica P46 pseudogene precludes P46 expression in this parasite
(Fig. S3). Since L. tropica does not depend on rodents for its zoo-
notic infection cycle, but on hyraxes and jackals (Talmi-Frank
et al., 2010a,b) the loss of functional P46 alleles may not be detri-
mental. L. infantum, a zoonotic parasite causing visceral leishman-
iasis in dogs and humans, but not known for using Muridae as
reservoir, also has a pseudogene in place of P46 (Reiling et al.,
2010).
Nevertheless, P46 is not an essential virulence factor. The dou-
ble allelic gene replacement mutants show an intermediate patho-
genicity and infectivity in vivo and in vitro respectively. While the
low in vitro infectivity of the null mutant can be overcome by a P46
transgene, we cannot at present attribute the in vivo phenotype to
the loss of P46 alone. This is due to the inability of the P46 trans-
gene to restore wild type level virulence in mice. Obviously, the
impact of P46 differs between in vitro infection of primary macro-
phage cultures and the far more complex situation in the BALB/c
mouse. In the latter model, the very high expression of P46 from
the transgene may have stimulating effects on the overall immune
response.
It is noteworthy that the Hsp100 null mutant too regained only
part of its virulence after transfection with Hsp100 (ClpB) trans-
genes (Hübel et al., 1997). Here too, expression of the transgene
was very high compared with wild type.
Lastly, we found P46 to be part of the immune-modulatory exo-
somes of L. major. In contrast to most other exosome marker pro-
teins (Silverman et al., 2010a,b), the presence of P46 does not
depend on the heat shock protein 100. This is in keeping with
the fact that P46 was ﬁrst characterised as a virulence restoring
factor in L. majorHsp100/mutants (Reiling et al., 2010). A depen-
dence on Hsp100 would have precluded that. Also, exosomes from
P46 null mutants had full pro-parasitic effect in ex vivo macro-
phages, indicating that P46 has no immune modulatory effect, in
keeping with previous results (Reiling et al., 2010).5. Conclusions
Our results show that P46 contributes to the virulence and
infectivity of L. major in vitro and in vivo.Moreover, it shows a geo-
graphic sequence variation that correlates with the prevalent, local
reservoir animal species, a variation that shows an impact in labo-
ratory model hosts. This raises the possibility, that P46 may be
involved in host adaption of L. major.
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